18 years and above of either sex <br/ > Hospital admission within 10 days of RT-PCR positivity for COVID-19 <br/ > SpO2 <94% at room air and require low flow oxygen support- through nasal canula, <br/ > venturi mask or non-rebreather mask <br/ > Normal procalcitonin- <0.4 ng/mL with no other evidence of any co- or secondary <br/ > bacterial, viral or fungal infection at the time of randomization <br/ > Considered to be an appropriate participant for intervention with an immunomodulatory <br/ > in the opinion of the investigator <br/ > Should be able to be maintained on venous thromboembolism prophylaxis or current <br/ > maintenance therapy during inpatient dosing period, according to institutional protocol

18 years and above of either sex <br/ > Hospital admission within 10 days of RT-PCR positivity for COVID-19 <br/ > SpO2 <94% at room air and require low flow oxygen support- through nasal canula, <br/ > venturi mask or non-rebreather mask <br/ > Normal procalcitonin- <0.4 ng/mL with no other evidence of any co- or secondary <br/ > bacterial, viral or fungal infection at the time of randomization <br/ > Considered to be an appropriate participant for intervention with an immunomodulatory <br/ > in the opinion of the investigator <br/ > Should be able to be maintained on venous thromboembolism prophylaxis or current <br/ > maintenance therapy during inpatient dosing period, according to institutional protocol